They performed a case-control gene-based association test of rare deleterious variants comparing European cases and controls (gnomAD: n = 7509 non-Finnish Europeans) and identified SOX17 as a novel PAH-CHD candidate risk gene [75]. This evidence concerns the gene SOX17 and coronary artery disorder.